Experts of the Pharmacoeconomics Department are involved in an EU4Health-project “Capacity building to support the uptake of biosimilars in a multistakeholder approach” (AUGMENT Biosimilars), acting as the consortium lead for the project.
The AUGMENT Consortium, together with the EU Health Policy Platform (EUHPP), invited all interested stakeholders to an upcoming #EUHPP Live Webinar: Under the title “Biosimilar Policies in Practice: Key Findings from the AUGMENT Study Visits”, the webinar, taking place on 19 October 2026 from 9.00-10.00 CET, provided insights into from study visits conducted in the second year of the AUGMENT Biosimilars Project.
Between April and July 2026, representatives of public authorities working on pharmaceutical pricing and reimbursement visited Poland, Norway, Portugal, France and Cyprus to learn more about biosimilar policies and practices from different countries. During the webinar, participants from public authorities shared their experiences, lessons learned and reflections on the implications for practice.
More information: https://biosimilars.goeg.at/
